Compare ALLY & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLY | COO |
|---|---|---|
| Founded | 1919 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.6B |
| IPO Year | 2011 | 1994 |
| Metric | ALLY | COO |
|---|---|---|
| Price | $41.83 | $63.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $54.42 | ★ $90.18 |
| AVG Volume (30 Days) | ★ 2.5M | 1.5M |
| Earning Date | 04-17-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 31.67 | N/A |
| EPS | ★ 2.11 | 0.27 |
| Revenue | ★ $7,914,000,000.00 | $2,532,800,000.00 |
| Revenue This Year | $24.30 | $6.66 |
| Revenue Next Year | $4.31 | $5.18 |
| P/E Ratio | ★ $20.04 | $250.70 |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $35.92 | $58.89 |
| 52 Week High | $47.29 | $89.83 |
| Indicator | ALLY | COO |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 23.13 |
| Support Level | $41.00 | $59.02 |
| Resistance Level | $42.30 | $73.39 |
| Average True Range (ATR) | 0.82 | 1.54 |
| MACD | 0.03 | -1.01 |
| Stochastic Oscillator | 25.35 | 2.96 |
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.